Last update:

Clinical pharmacology news

GLP-1-based meds are linked to fewer heart events in adults with obesity, autoimmune disease

Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) medication had lower rates of emergency department visits and were less likely to experience serious ...

Antibody fragment prevents hemorrhages associated with new Alzheimer's treatments

In 2025, the European Medicines Agency approved two antibodies for Alzheimer's disease: lecanemab (LeqembiTM, from Biogen) and donanemab (Kisunla, from Eli Lilly and Co.), both based on immunotherapy (the use of molecules ...

Flu drugs show promise against cognitive decline

A class of flu drugs may reduce cognitive decline and premature aging in people living with chronic viral infection, reports a new study led by Northwestern University that began with blood samples from people with HIV and ...

Mathematical modeling tackles the human psychedelic experience

Psychedelic drug experiences are among the most fascinating but mysterious journeys of the human mind. Long the domain of indigenous shamans and modern "psychonauts" who seek self-discovery, the sensory-rich experiences often ...